hEDS diagnostic criteria checker
The 2017 international criteria for hypermobile Ehlers-Danlos syndrome, one criterion at a time
Hypermobile Ehlers-Danlos syndrome (hEDS) is diagnosed clinically against the criteria published by the International Consortium on the Ehlers-Danlos Syndromes in 2017. There is no genetic test. The criteria are usually distributed as a one-page PDF checklist written for clinicians. This page walks through the same three criteria interactively, in plain language, showing you at each step which items you meet, which you do not, and which can only be settled by a doctor. Notably, POTS, fatigue, and gut symptoms are common alongside hEDS but are not part of the criteria.
hEDS needs all three criteria at once. Criterion 1 is generalised joint hypermobility on the Beighton score, with the five-part questionnaire filling in when your score is one point short of the age cut-off. Criterion 2 asks for two of three features: systemic signs of a connective tissue disorder, family history, and musculoskeletal complications. Criterion 3 is a set of exclusions that only a clinician can confirm.
Joint hypermobility is common in people with POTS and other forms of dysautonomia, and a hypermobility assessment is a reasonable part of a post-viral work-up when joints, skin, or pain fit the picture. If you only want the hypermobility score, use the Beighton tool; if you completed it recently on this device, this page will offer to reuse your score.
How your answers map to the 2017 hEDS criteria
Reading this result
hEDS requires Criteria 1, 2, and 3 simultaneously. Criteria 1 and 2 can be substantially self-assessed, which is what this page does; Criterion 3 cannot. A clinician also verifies the Feature A signs during examination, and the Beighton score is more reliable when a clinician measures it with a goniometer. Treat the result as a structured summary to bring to an appointment, not a conclusion.
If you have generalised joint hypermobility with symptoms but do not meet the full criteria, the 2017 framework describes this as a hypermobility spectrum disorder (HSD). The management of HSD and hEDS is the same, and the strictness of the hEDS criteria is deliberate: it was designed to define a tighter group for genetic research.
People with hypermobility often also have orthostatic symptoms. The NASA lean test records the heart-rate response a POTS assessment needs, and the COMPASS-31 profiles autonomic symptoms across six domains.
This is not a diagnosis. Discuss your results with your GP, a rheumatologist, or a clinical geneticist.
Results copied to clipboard.